LOUISVILLE, Ky. (WAVE) - The Asclepius Initiative’s Founder and CEO Dr. Susan Bornstein, MD, MPH and Health Researcher Melissa Eggen, PhD join Maira Ansari to discuss the results of their Kentucky ...
Results of AFU-GETUG-20: A randomised phase 3 trial of adjuvant androgen deprivation therapy with leuprorelin acetate after radical prostatectomy in patients with high-risk localized prostate cancer.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A St. Louis firm that said it worked on stem cell therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results